← Back to all trials
Not Yet Recruiting
NCT05618379
Adult Spinal Muscular Atrophy (SMA) China Registry
Conditions: Muscular Atrophy, Spinal
Sex: All
Ages: 18 Years – N/A
Enrollment: 200
Sponsor: Biogen
Summary
The primary objective of the study is to describe the natural history and utilization of disease modifying therapy (DMT) among adult Chinese participants with SMA linked to chromosome 5q (5q-SMA).
Eligibility Criteria
Key Inclusion Criteria:-Genetically confirmed 5q-SMA.Key Exclusion Criteria:-Other types of SMA (non 5q-SMA).NOTE: Other protocol defined Inclusion/Exclusion criteria may apply
Source: ClinicalTrials.gov (NCT05618379). StuddyBuddy aggregates publicly available trial information.
